Exelixis Inc
NASDAQ: EXEL
$22.52
+$0.03 (+0.1%)
Closing price April 19, 2024
Public offerings of stock tempted some insider buying, and one insider stepped up to support a struggling online delivery service provider.
Published:
Friday's top analyst upgrades and downgrades included Datadog, DexCom, Exelixis, Lam Research, Las Vegas Sands, Lyft, Match, Nasdaq, Next Era Energy, Norfolk Southern, Pfizer, Walmart and Wolfspeed.
Published:
Thursday's top analyst upgrades and downgrades included AT&T, Alibaba, Ally Financial, BioMarin Pharmaceutical, Box, Citrix Systems, Nio, Schlumberger and TJX Companies.
Published:
Tuesday’s top analyst upgrades and downgrades included Campbell Soup, Exact Sciences, Exelixis, Pool, Spirit Airlines and ZTO Express.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including BioNTech, Denali Therapeutics, Exelixis, Foot Locker and Hostess Brands.
Published:
Thursday's top analyst upgrades and downgrades included Adobe, Baker Hughes, Best Buy, Cisco Systems, CyberArk Software, Enphase Energy, Grubhub, Jumia Technologies, SmileDirectClub, Under Armour and...
Published:
Exelixis stock jumped early on Monday after the company, in conjunction with Bristol-Myers Squibb, announced positive late-stage results from its kidney cancer study.
Published:
The top analyst upgrades, downgrades and initiations seen on Monday included Chipotle Mexican Grill, Delphi Technologies, Dollar General, Facebook, Ingersoll-Rand, Nike, Okta and Quest Diagnostics.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and...
Published:
Last Updated:
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
Published:
Last Updated:
Sears, Weyerhaeuser, Laredo Petroleum, and Exelixis were among the stocks posting new 52-week lows Monday.
Published:
Last Updated:
Exelixis shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory differentiated thyroid cancer (DTC).
Published:
Last Updated:
JD.com, Turquoise Hills, Exelixis, and Floor & Decor Holdings all posted new 52-week lows Monday.
Published:
Last Updated:
Invesco, Tal Education, Chemours, and Exelixis all posted new 52-week lows on Thursday.
Published:
Last Updated:
SeaChange, Sears, Exelixis, and Adamis Pharma all posted new 52-week lows Tuesday.
Published:
Last Updated: